
Zydus gets USFDA nod for generic version of Copaxone for treatment of Multiple Sclerosis
Zydus Lifesciences Limited announced on Thursday that it has received final approval from the United States Food and Drug Administration (USFDA) for its Glatiramer Acetate Injection, a generic version of Copaxone® in 20 mg/mL and 40 mg/mL strengths …